You can view the list of prize winners at the WMS-13 Newcastle congress, which has long become an annual tradition.
WMS 2008 Young Investigator Prizes | ||||||||
Presentation | Page | Author | Title | |||||
Lea Rose Prize: | ||||||||
GP4.12 | 39 | Christopher Heier | Translational readthrough modulates SMN stability: Potential for aminoglycosides as an SMA therapy | |||||
President's Prize: Young Myologist of the Year | ||||||||
GO.5 | 43 | Martin Krahn | Partial functionality of a mini-dysferlin molecule identified in a patient affected with a moderately severe primary dysferlinopathy | |||||
President's Prize: First Time Presenter | ||||||||
DP4.11 | 48 | Capucine Trollet | Expression and siRNA targeting of PABPN1 as a model for oculopharyngeal muscular dystrophy (OPMD) | |||||
Elsevier Prizes (4) | ||||||||
TO.1 | 56 | Debbie Hicks | Cyclosporin A as a potential treatment for collagen VI-related muscular dystrophy: a cellular study of mitochondrial dysfunction and its rescue | |||||
GP1.05 | 31 | Yaqun Zou | siRNA mediated allele specific selective silencing of a dominant negative COL6A3 mutation causing UCMD | |||||
GP14.14 | 52 | Sherine Shalaby | Novel FHL1 mutations in fatal and benign reducing body myopathy | |||||
GP5.02 | 40 | Ingrid Muth | Upregulation of αβ-crystallin interrelates with APP and precedes accumulation of β-amyloid in the muscle of sporadic inclusion body myositis | |||||
Subscription Prizes | ||||||||
1 | GO.2 | 29 | Joachim Schessl | Proteomic identification of the LIM domain protein FHL1 as the gene-product mutated in reducing body myopathy | ||||
2 | DP1.10 | 30 | Valeria Ghiaroni | Structural and functional characterization of muscle fibers in the novel mouse model of facioscapulohumeral muscular dystrophy | ||||
3 | DP3.11 | 40 | Eva Brauers | Influences of caveolin-3 mutations on canonical signaling pathways | ||||
4 | GP14.04 | 52 | Jaakko Sarparanta | Interactions of myospryn with M-band titin and calpain-3 | ||||
5 | GP3.13 | 36 | Stefanie Bulst | Supplementation studies in primary human muscle cells with mtDNA depletion caused by mutations in the DGUOK and POLG1 genes. | ||||
6 | GP3.15 | 37 | Michael Trenell | Waking the sleeping giant; habitual physical inactivity in people with mitochondrial disease | ||||
7 | GP7.10 | 43 | Aniko Keller-Pinter | Myostatin interacts with syndecan-4 and PKC-alpha in skeletal muscle | ||||
8 | TP1.10 | 33 | Kristy Rose | Reliablity and validity of measuring foot and anlke muscle strength in very young children | ||||
9 | TP2.10 | 38 | Hifang Yin | Restoration of dystrophin expression in mdx mouse by peptide-conjugated antisense oligonucleotides | ||||
10 | TP2.15 | 38 | Stefania Corti | Treatment of spinal muscular atrophy by transplantation of embyronic (ES) derived neural stem cells | ||||
11 | TP4.06 | 51 | Olivier Dorchies | Green tea polyphenols and pentoxifylline stimulate dystrophic myotube formation and maturation in primary cultures | ||||
12 | MP1.01 | 35 | Violeta Mihaylova | Molecular characterization of congenital myasthenic syndromes in Southern Brazil | ||||
13 | GP10.05 | 46 | Mark Hornsey | Preclinical drug trials investigating potential treatements for dysferlin deficiency |